Loading clinical trials...
Loading clinical trials...
A Phase 2 Multicenter, Open-label, Randomized, Parallel-group, Multiple-dose Study to Assess the Effectiveness, Safety and Satisfaction With Collagenase Clostridium Histolyticum Grid Technique Injections of Buttock or Thigh Cellulite With Laxity in Adult Females
Conditions
Interventions
collagenase clostridium histolyticum
Locations
3
United States
Endo Clinical Trial Site #3
Coral Gables, Florida, United States
Endo Clinical Trial Site #2
Metairie, Louisiana, United States
Endo Clinical Trial Site #1
New York, New York, United States
Start Date
October 1, 2020
Primary Completion Date
August 30, 2021
Completion Date
September 24, 2021
Last Updated
September 28, 2022
NCT05664581
NCT04998578
NCT03782545
NCT05959681
NCT05885035
NCT05632926
Lead Sponsor
Endo Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions